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Helicobacter pylori (Hp) infection is an established causative agent for gastric cancer. Although the 
oral cavity is a part of the gastrointestinal system, the presence and possible causative role of Hp in 
oral squamous cell carcinoma (oScc) is a subject of controversy. therefore, the current study aimed to 
investigate HP infection in two cohorts of OSCC patients with different demographic characteristics, 
lifestyles and habitual risk factors. A total of 242 formalin-fixed paraffin-embedded OSCC specimens 
from two different patient cohorts (Norway, n = 171 and Nepal, n = 71) were used to examine HP using 
immunohistochemistry (IHC) and quantitative polymerase chain reaction (qPCR). Two different HP 
specific genes (23S rRNA and ureA) were used for TaqMan-based qPCR, and for subsequent verification 
using HP specific RIDAGENE HP kit and SYBR Green based qPCR. All of the OSCC specimens from both 
cohorts were found to be negative for Hp infection with iHc and qpcR, although the positive control 
specimens tested positive. Our findings suggest that HP is absent in the examined OSCC cohorts, 
irrespective of race, lifestyle and habitual risk factors. this indicates that, in contrast to gastric cancer, 
Hp is an unlikely contributing factor for oScc pathogenesis.
Oral cancer is a highly aggressive malignant tumor arising from the anterior 2/3 of tongue, buccal mucosa, gin-
giva, floor of the mouth and hard palate. Oral squamous cell carcinoma (OSCC), the most common histologic 
variant, represents more than 90% of oral cancer cases1. Combined with malignancies in the lip and pharynx, 
oral cancer ranks as the 7th most common cancer type worldwide with approximately 300 000 deaths every year2. 
Despite improvements in the diagnostic and treatment modalities, 5-year survival of OSCC patients remains 
around 60%3. Smokeless tobacco (such as betel quid, ghutka), alcohol and smoking are the most important risk 
factors for OSCC in Southeast Asia; whereas smoking and alcohol are important in the western countries4,5. 
Nevertheless, a fraction of OC cases cannot be linked to the aforementioned risk factors. This indicates the pos-
sibility of other factors including microorganisms in the pathogenesis of OSCC. Indeed, approximately 20% of 
human malignancies have been attributed to microorganisms6. In this context, it is worth mentioning that the 
oral cavity harbors approximately 700 different bacterial species7, and dysbiosis of several of the oral bacteria 
has been reported in OSCC specimens and/or brush biopsies and saliva from OSCC patients as compared to the 
normal controls8–11.
Helicobacter pylori (HP) is a gram negative, spiral-shaped bacterium, which is estimated to infect the stom-
ach of almost half of the world’s population. HP was considered to be a class I carcinogen by the International 
Agency for Research on Cancer Working Group in 199412. HP infection is considered to be the most common 
cause of infection-related cancers, particularly gastric cancer along with MALT lymphoma13,14. Elimination of 
HP infection is associated with the reduction in the risk of gastric cancer development from the HP infected 
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gastric precancerous lesions, further supporting the link with gastric carcinogenesis15. HP can be divided into 
CagA-positive and CagA-negative types based on the presence or absence of cytotoxin-associated gene A (CagA). 
CagA-positive HP are considered more carcinogenic than the CagA-negative type. At the molecular level, CagA 
protein (encoded by CagA gene) is delivered into the gastric epithelial cells by a bacterial type IV secretion sys-
tem, which in turn deregulates SHP2 oncoprotein and its downstream signaling pathways, thereby contributing 
to the transformation of gastric epithelial cells16.
HP has been shown to be present in dental plaque and saliva17 and to colonize different parts of the oral cavity 
(reviewed in18). HP infection has been linked to several disease conditions in the oral cavity, such as stomatitis, 
glossitis and periodontitis17,19. Given the role of HP in gastric carcinogenesis and observations that HP could 
colonize and lead to inflammatory conditions in the oral cavity, one could hypothesize that HP infection might be 
related to the development of oral precancer and cancerous lesions, at least in a subset of HP positive lesions. Only 
a handful of studies have attempted to look at the presence of HP in OSCC, with conflicting results20–23. Some 
studies have linked the presence of HP with oral cancer progression; others have shown no significant association 
or even protective effect20,22,24. Interestingly, betel chewing has been reported to be associated with higher risk for 
HP infection in OSCC21, indicating that OSCC-related habitual risk factors might influence the susceptibly for 
HP infection. This study aimed to investigate HP infection status in two cohorts of OSCC specimens, one from 
Nepal and one from Norway, with differing race, lifestyle and habitual risk factors for OSCC, by using immuno-
histochemistry (IHC) and quantitative polymerase chain reaction (qPCR).
Results
clinicopathological characteristics of oScc. The clinicopathological characteristics of the specimens 
used are summarized in Supplementary Table S1,S2. Briefly, the median age of Nepalese OSCC cases was 56 years, 
and that of Norwegian cases was 66. The male to female ratio for Nepalese cases was 3:1, whereas for Norwegian 
cases it was 1.5:1.
iHc. The positive control (gastric biopsies) showed brown colored rod/filament shaped HP mostly located in 
the gastric pits (Fig. 1A). However, all of the formalin-fixed paraffin-embedded (FFPE) OSCC specimens (n = 71) 
from Nepal tested negative for HP with IHC (Fig. 1B).
DNA yield, sensitivity and amplification of TaqMan based qPCR assay. The range of DNA yield 
from OSCC FFPE sections was between 1.4 to 575 ng/ µl. Only 5.7% (n = 14) of samples yielded DNA concentra-
tion of less than 10 ng/µl. The purity (260/280 ratio) of 95% of samples (n = 230) was higher than 1.8.
Amplification of serially diluted DNA from positive control DNA showed that as little as 6 femtograms could 
be amplified by the TaqMan based assay (Fig. 2A,B). The amplification of ureA and 23S rRNA was found to be 
95% and 87% efficient, respectively (data not shown).
Amplification of HP specific genes using in-house TaqMan based qPCR assay. Among the OSCC 
specimens (n = 242) from Norway and Nepal, the human HBB gene (coding for human beta globulin) could not 
be amplified in 7.02% of samples (n = 17), indicating poor quality of DNA and were therefore excluded from the 
study. All of the remaining OSCC specimens (n = 225) tested negative for HP specific genes with TaqMan based 
assay. Nevertheless, DNA from positive controls tested positive for both 23S rRNA and ureA genes (Fig. 2A–C).
Amplification of HP specific genes using RIDAGENE HP kit. DNA from the OSCC specimens were 
examined by using an independent RIDAGENE HP kit PCR. The DNA from positive controls resulted in good 
amplification of internal control DNA and HP specific genes (Fig. 2D,E). Despite the good amplification of inter-
nal control DNA, HP specific genes could not be amplified from DNA from OSCC samples (Fig. 2D,E).
Amplification of HP specific genes using SYBR green-based qPCR assay. Although HP specific 
genes were amplified for the DNA from positive controls, none of the tested OSCC samples showed amplification 
for these genes (data not shown).
Discussion
Using two different detection techniques (IHC and qPCR), the current work aimed to investigate HP infection in 
two different OSCCs cohorts (Norway and Nepal) differing with respect to race, lifestyle and habitual risk factors 
for OSCC.
Several methods (culture, serology, rapid urease test, histology/IHC, PCR) are available for the detection of 
HP in different types of specimens, each with some advantages and limitations25. The combination of qPCR and 
IHC was chosen in the current study as the use of these methods in FFPE specimens has been well assessed for 
HP detection with reasonably high sensitivity and specificity26. qPCR, being a highly sensitive method, is very 
sensitive to the quality of DNA input, well designed primer pairs and selection of proper detection chemistry27. To 
address these issues, several quality control measures were used in the current study. Firstly, all OSCC specimens 
with Ct values of >37 or not amplified for human HBB gene, indicating a poor quality of isolated DNA, were 
excluded from the study (Fig. 2C). Secondly, serial dilution series of DNA from the positive controls were used to 
examine the amplification efficiency (95% for ureA and 87% for 23S rRNA) of the in-house TaqMan PCR system 
(Fig. 2A,B). Indeed, our in-house TaqMan PCR protocol was able to amplify bacterial DNA template from as little 
as 6 femtograms. Thirdly, commercially available RIDAGENE HP kit was used to confirm the results of in-house 
TaqMan qPCR. Moreover, internal control DNA included in the RIDAGENE HP kit suggested that there was no 
obvious inhibition to PCR amplification due to possible carry-over components in the DNA template (Fig. 2D,E). 
Finally, independent validation using a SYBR Green-based qPCR corroborated the results from in-house TaqMan 
qPCR and RIDAGENE HP kit. Similarly, proper positive and negative controls were used for IHC to ensure the 
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validity of the method. These measures ensure that the HP test protocols in the current study were accurate and 
reproducible.
In the current study, none of the OSCC samples was found to be HP positive with IHC, although the posi-
tive control gastric biopsy demonstrated HP infection, primarily in the gastric pit (Fig. 1A). Supporting these 
results, HP specific genes (ureA and 23SrRNA) were not amplified by qPCR in any of the OSCC specimens, 
although they were readily amplified in the positive controls (Fig. 2A–D). The current findings are in line with 
some previous studies reporting either an absence or lower rate of HP positivity in dental plaque, saliva or OSCC 
specimens, thereby questioning a causative role for HP in OSCC development28–31. However, another study has 
reported a higher rate of HP positivity (21.5%) in OSCC specimens, suggesting a link between HP and OSCC22. 
Interestingly, several other studies have found a relatively high HP seropositivity in OSCC patients as well as in 
healthy controls and suggested that either HP is not linked to OSCC or it can even have a protective effect on 
OSCC pathogenesis20,21,24. Overall, these observations cannot establish a role for HP in OSCC, either as carcino-
genic or as a protective factor.
Several factors such as type and size of sample used, sample collection procedure, methodology used, and 
type of population studied might be responsible for these variable observations. Indeed, with the exception of 
the study by Grimm et al.22, a majority of the above-mentioned studies have used relatively smaller sample sizes. 
Moreover, there exists a wide variation in the sensitivities of different test methods (Supplementary Table S3). 
Positive serology and rapid urease test do not necessarily reflect the true HP status in biopsy specimens exam-
ined32,33. The current study benefited from the use of a large cohort of OSCCs and two different detection meth-
ods, with subsequent independent validation protocols. There is a wide variation in HP prevalence with respect 
to geography, race and lifestyle34,35. Betel chewing, a common habit in Southeast Asia, has been suggested to 
predispose for HP infection in oral cavity21. Absence of HP in both Nepalese and Norwegian cases with 36.6% and 
0% cases with history of betel chewing respectively, suggest that betel quid might not predispose for HP infection 
in OSCC.
Figure 1. HP could not be detected in OSCC using IHC. (A) Representative images of gastric mucosal biopsy 
demonstrating presence of HP in gastric pits (red arrows). (B) Representative images of OSCC showing absence 
of HP both in the superficial (b1) and deeper parts (b2) of the lesion.
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The current study has limitations. Although excluded from the analysis, about 7% OSCC cases were found 
to have a lower DNA quality, and availability of corresponding fresh tissues for at least for some of FFPE tissues 
would have been useful to examine the effect of DNA quality. The current study lacks information on the prior 
use of antibiotics (triple therapy), as it has been shown to eliminate HP from oral cavity in 40% of individuals36. 
In addition, oral health status17 as well as information on concurrent HP status in stomach37, considered to be 
important determinants for oral HP, are also unavailable. In conclusion, although oral cavity (dental plaque and 
saliva) has been considered as a primary extragastric reservoir for HP, the results of the current study suggest that 
Figure 2. HP could not be detected in OSCC using qPCR. Representative amplification curves for HP specific 
ureA (A) and 23S rRNA (B) genes using serial dilutions of DNA (starting concentration was 12 ng/µL) from HP 
culture. (C) Image illustrating amplification curves for HP specific ureA (1) and 23S rRNA (2) genes in DNA 
from positive control gastric biopsy and human HBB (3) gene in OSCC cases. (D and E) Image illustrating 
amplification curves for internal control DNA gene and HP specific genes using RIDAGENE HP kit. Curves in 
blue color in represent amplification curves for 16S rRNA gene for positive control (1) included in the kit and 
positive control gastric biopsies (4). Majority of curves in green color (labelled as 5 and 6 in figure) represent 
amplification curves for internal control gene in OSCC samples, positive control gastric biopsies and negative 
control (for details, see labels in figure).
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HP is uncommon in OSCCs irrespective of race, lifestyle and habitual risk factors; and is an unlikely contributing 
factor for OSCC pathogenesis.
Material and Methods
Specimens. The tissue samples used in the current study consisted of FFPE archival OSCC specimens from 
Nepal (Chitwan) and Norway (Bergen). The specimens were collected respectively from B.P. Koirala Memorial 
Cancer Hospital (BPKMCH) (between 2011 and 2014) and Haukeland University Hospital (between 1998 and 
2012). Informed consent was obtained from all participating patients. Collection of specimens from Nepal was 
approved by the Committee for Medical and Health Research Ethics in West Norway (2011/1244 REK vest) and 
Nepal Health Research Council (ref 526/2012); and specimens from Bergen by the Committee for Medical and 
Health Research Ethics in West Norway (2010/481 REK vest). A total number of 242 FFPE OSCCs (n = 71 from 
Nepal and n = 171 from Norway) were used for DNA qPCR, whereas 71 OSCCs (all from Nepal) were used for 
HP IHC. Protocols used for the tissue collection, processing (formalin fixation and paraffin embedding) and stor-
age at BPKMCH were similar to that at Haukeland University Hospital. Briefly, diagnostic/surgical biopsy spec-
imens were fixed in 10% neutral buffered formalin for up to 48 hours (depending on the size of the specimens), 
dehydrated using increasing ethanol concentrations and xylene, and embedded in paraffin. All methods were 
performed in accordance with the relevant ethical guidelines and regulations of the University of Oslo, where the 
experiments were performed.
iHc. A total of 71 (n = 71) FFPE specimens of OSCC from Nepal (specimens from Norway were not used for 
HP IHC), were used for the immunohistochemical detection of HP. The details of the clinicopathological param-
eters of the OSCC patients are summarized in Supplementary Tables S1,S2. Four-micron thick FFPE sections 
were deparaffinized in xylene, rehydrated in decreasing concentrations of ethanol and antigen retrieval was done 
by pressure cooker treatment in Tris-EDTA buffer, pH 9.0 (Cat. no: S2367 DAKO). Blocking was done with 10% 
goat serum in 3% bovine serum albumin for 30 min at room temperature. Polyclonal rabbit anti-HP primary 
antibody (Code B047, DAKO, 1:100 dilutions) was applied for 45 minutes at room temperature. After inactivation 
of peroxidase by incubating with DAKO REAL (code S2023, DAKO) peroxidase blocking solution, anti-rabbit 
secondary antibody conjugated with horseradish peroxidase labeled polymer (EnVision System, DAKO) was 
applied for 30 min. Presence of antigen was visualized by staining with 3, 3′-diaminobenzidine (DAB, DAKO), 
counterstained with hematoxylin (DAKO) and mounted with EUKITT mounting medium. Sections incubated 
only with antibody diluent (Cat. no: S0809, DAKO) instead of primary antibody served as negative controls. HP 
positive human gastric samples, regularly used as positive controls at the diagnostic lab at the Department of 
Pathology, Haukeland University Hospital, were used as positive controls in the current study. IHC was evaluated 
by SP and DS using Nikon E90i microscope equipped with DS-Ri1 camera using the NIS-elements software.
DNA extraction. Serially cut tissue sections (7 μm) from FFPE tissues (n = 242) were used for extraction of 
DNA. New microtome blade was used for sectioning every new sample. Additionally, microtome was thoroughly 
cleaned with DNA removal solution (DNA AWAY, Cat. no: 7010, Molecular BioProducts, USA) before and after 
sectioning of each paraffin block. The first paraffin section was discarded to minimize the effect of oxidized DNA 
on the surface of FFPE block. Several incubation times and temperatures for the treatment with proteinase K were 
tested and overnight incubation at 56 °C was found to be most efficient for DNA extraction from OSCC samples. 
Treatment with MetaPolyzyme (enzyme cocktail to break down the cell wall of bacteria, Sigma-Aldrich, Cat. no: 
MAC4L) was found not to improve DNA yield and amplification of HP genes in the positive control samples, and 
therefore was not used for DNA isolation. Following the manufacturer’s instructions, QIAamp DNA FFPE Tissue 
Kit (QIAGEN, cat. no: 56404) was used for DNA extraction from FFPE sections. Briefly, eight to ten consecutive 
sections, depending upon the size of available tissue in FFPE blocks, were placed in a 1.5 ml eppendorf tube with 
the help of disposable long neck pipette tips. The tissue was deparaffinized in xylene and ethanol, and digested 
with proteinase K overnight at 56 °C. DNA was eluted in 75 µl volume of ATE buffer. DNA concentration was 
measured with a NanoDrop 2000cSpectrophotometer (ND-1000, Thermo Fisher Scientific, Wilmington, DE, 
USA).
primer design and qpcR. Primer pairs and corresponding TaqMan probe sequences for two different HP 
specific genes (23S rRNA38, ureA39) (Table 1) were modified, and used for TaqMan- and SYBR- based qPCR 
systems. Primer pairs specific to human HBB gene (coding for Beta globulin)40 was used to assess the quality of 
isolated DNA. Serially diluted DNA isolated from HP positive gastric biopsy and HP culture (CCUG 39500 T) 
was used to examine the amplification efficiency, optimal reaction conditions (DNA input, primer and probe 
concentrations and cycling conditions) as well as used as positive controls. Samples where DNA template was 
replaced with an equal volume of sterile water served as negative controls.
Target gene primer sequence (5′ to 3′) probe sequence (5′ to 3′)
size 
(bp) reference
ureA F: GCGTGGCAAGCATGATCCATR: GGGTATGCACGGTTACGAGTTT CAGGAAACATCGCTTCAATACCCACT 77
39
23S rRNA F: AGGTGAAAATTCCTCCTACCR: TCTCAAGGATGGCTCCATAAG CAAAGCCTCCCACCTATCCTGC 146
38
HBB F: TGCCTATCAGAAAGTGGTGGCTR: GCTCAAGGCCCTTCATAATATCC TGGCTAATGCCCTGGCCCACAA 149
40
Table 1. Table showing the details of primers and probes used in the study. bp: base pairs, F: forward; R: reverse.
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taqMan pcR assays. Following manufacturers’ instructions, up to 200 nanograms of DNA per sample was 
used in a 20 μl reaction volume in 96-well PCR plate (ABgene, cat.no AB-0600) for PCR amplification of respec-
tive genes using Mx3005P qPCR system in a single replicate. Briefly, the 20 μl reaction mixture contained 10 μl 
of 2x Brilliant III Ultra-Fast qPCR master mix (Agilent Technologies, cat. No: 600880-51), 2 μl probe (5 µM) and 
primer (2,5 µM) mixture, 0,3 μl of Rox 1/500, 2,7 μl of nuclease free water and 5 µl of DNA. Master mix contained 
a mixture of mutant Taq DNA polymerase, dNTPs, MgCl2 (5.5 Mm) and a buffer specially formulated for fast 
cycling. PCR amplification was performed in Mx3005P qPCR system using the following cycling conditions: 
initial denaturation at 95 °C for 5 min followed by 45 amplification cycles (95 °C for 10 sec, and 60 °C for 30 sec). 
The data were analyzed with MxPro qPCR Software version 4.10. Samples with more than 37 Ct values were 
considered negative41.
SYBR green PCR assays. Amplification efficiency of the primers (Table 1) were examined by using an 
independent master mix chemistry, SYBR green (SsoAdvanced Universal SYBR Green Supermix, BIO-RAD, 
cat. no: 1725271). Additionally, 9 OSCC where human HBB gene could not be amplified with TaqMan system, 
were examined using SYBR green system. The concentrations of the primers and template DNA, and the cycling 
conditions were same as that for TaqMan system.
Verification with RIDAGENE HP kit. Presence of HP DNA in the OSCC samples and positive control 
was also examined by using RIDAGENE HP kit (cat. no: PG2305, r-biopharm). Previous studies have shown 
excellent sensitivity and specificity of this kit for the detection of HP in gastric biopsy42. This kit is based on 
Taq-polymerase enzyme chemistry and consists of primer pairs/probes for the HP specific genes and internal 
control DNA. Randomly selected OSCC samples (n = 60) and positive control DNA from gastric biopsy and HP 
culture were used for this kit. Following the manufacturer’s instructions, up to 100 nanograms of DNA template 
was used for PCR amplification.
Data availability
The datasets generated during the current study are available from the corresponding author on reasonable 
request.
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